Company news

Neurotech International Ltd. news in 2025

Neurotech International Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Binding Commitments Received for a $4 Million Placement

December 16, 2025

Trading Halt

December 14, 2025

Neurotech receives $4.73m R&D Tax Incentive Refund

November 11, 2025

US FDA Rare Pediatric Disease Designation in Rett syndrome

October 7, 2025

Appendix 4E & Annual Report to shareholders

August 29, 2025

Positive Human PK Study Results for NTI164

June 1, 2025

NTI164 Preclinical Toxicology Studies Update

May 5, 2025

Appendix 4D and Half Year Accounts

February 27, 2025

Positive Opinion on OMPD for NTI164 in Europe

February 27, 2025

NTI Signs Development Agreement for Cannabinoid Therapies

February 12, 2025

Neurotech Receives $2.44 Million R&D Tax Incentive Refund

January 30, 2025

Decks in 2025